CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr Eiji Yoshihara PhD |
Quest – Discovery Stage Research Projects |
Dual angiogenic and immunomodulating nanotechnology for subcutaneous stem cell derived islet transplantation for the treatment of diabetes |
$250,000 |
University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Quest – Discovery Stage Research Projects |
Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia |
$219,230 |
University of California, San Diego |
Dan S Kaufman |
Quest – Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor-expressing macrophages for cancer treatment |
$222,200 |
Stanford University |
Alan G Cheng |
Quest – Discovery Stage Research Projects |
Modulation of the Wnt pathway to restore inner ear function |
$1,389,416 |
University of California, San Diego |
Prof James S Hagood |
Quest – Discovery Stage Research Projects |
Mesenchymal stem cell extracellular vesicles as therapy for pulmonary fibrosis |
$0 |
University of Southern California |
Dr. Neil Segil |
Quest – Discovery Stage Research Projects |
A screen for drugs to protect against chemotherapy-induced hearing loss, using sensory hair cells derived by direct lineage reprogramming from hiPSCs |
$741,574 |
Salk Institute for Biological Studies |
Ronald Mark Evans |
Quest – Discovery Stage Research Projects |
Therapeutic immune tolerant human islet-like organoids (HILOs) for Type 1 Diabetes |
$1,637,209 |
Gladstone Institutes, J. David |
Li Gan |
Quest – Discovery Stage Research Projects |
Develop iPSC-derived microglia to treat progranulin-deficient Frontotemporal Dementia |
$1,547,157 |
University of California, Los Angeles |
Dr. Lili Yang |
Quest – Discovery Stage Research Projects |
Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer |
$1,404,000 |
University of California, San Diego |
Dr. Eric D. Adler MD |
Quest – Discovery Stage Research Projects |
Genetically Modified Hematopoietic Stem Cells for the Treatment of Danon Disease |
$1,393,200 |
Stanford University |
Dr. Katja Weinacht |
Quest – Discovery Stage Research Projects |
Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome |
$1,251,720 |
City of Hope, Beckman Research Institute |
Dr Saul J Priceman |
Quest – Discovery Stage Research Projects |
Chimeric Antigen Receptor-Engineered Stem/Memory T Cells for the Treatment of Recurrent Ovarian Cancer |
$1,351,174 |
Stanford University |
Dr. Philip Arden Beachy PhD |
Quest – Discovery Stage Research Projects |
Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer |
$1,265,436 |
Scripps Research Institute |
Stuart A Lipton |
Quest – Discovery Stage Research Projects |
Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs |
$1,827,576 |
University of California, San Francisco |
Dr. Hideho Okada |
Quest – Discovery Stage Research Projects |
Non-viral reprogramming of the endogenous TCRα locus to direct stem memory T cells against shared neoantigens in malignant gliomas |
$900,000 |
Children’s Hospital of Los Angeles |
Dr. Mark R Frey |
Quest – Discovery Stage Research Projects |
Universal Pluripotent Liver Failure Therapy (UPLiFT) |
$1,297,512 |
University of California, San Diego |
Dr. Jonathan H Lin |
Quest – Discovery Stage Research Projects |
Small Molecule Proteostasis Regulators to Treat Photoreceptor Diseases |
$1,153,937 |
University of California, Irvine |
Dr. Aileen J Anderson |
Quest – Discovery Stage Research Projects |
Generation and in vitro profiling of neural stem cell lines to predict in vivo efficacy for chronic cervical spinal cord injury. |
$1,575,613 |
University of California, San Francisco |
Dr. Shuvo Roy |
Quest – Discovery Stage Research Projects |
Silicon Nanopore Membrane encapsulated enriched-Beta Clusters for Type 1 Diabetes treatment |
$1,113,000 |
University of California, Los Angeles |
Dr. Scott G Kitchen |
Quest – Discovery Stage Research Projects |
Engineering Lifelong Cellular Immunity to HIV |
$1,701,178 |
University of California, San Diego |
Dr. Tannishtha Reya |
Quest – Discovery Stage Research Projects |
Targeting Cancer Stem Cells in Hematologic Malignancies |
$1,960,560 |
University of California, Los Angeles |
Dr. Thomas Carmichael M.D., Ph.D. |
Quest – Discovery Stage Research Projects |
iPS Glial Therapy for White Matter Stroke and Vascular Dementia |
$2,086,130 |
University of California, Los Angeles |
Dr. April Pyle Ph.D. |
Quest – Discovery Stage Research Projects |
Identification and Generation of Long Term Repopulating Human Muscle Stem Cells from Human Pluripotent Stem Cells |
$2,148,519 |
Stanford University |
Dr. Kyle M Loh |
Quest – Discovery Stage Research Projects |
Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells |
$1,968,456 |
University of California, San Diego |
Mark H Tuszynski |
Quest – Discovery Stage Research Projects |
Neural Stem Cell Relays for Severe Spinal Cord Injury |
$1,638,900 |
Stanford University |
Dr. Helen M Blau |
Quest – Discovery Stage Research Projects |
Stimulating endogenous muscle stem cells to counter muscle atrophy |
$2,198,687 |
ViaCyte, Inc. |
Dr. Alan D. Agulnick |
Quest – Discovery Stage Research Projects |
Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes |
$1,470,987 |
University of California, San Diego |
Dr Yang Xu |
Quest – Discovery Stage Research Projects |
Development of immune invisible beta cells as a cell therapy for type 1 diabetes through genetic modification of hESCs |
$1,924,791 |
Neurona Therapeutics |
Dr. Cory R Nicholas |
Quest – Discovery Stage Research Projects |
Development of a Cellular Therapeutic for Treatment of Epilepsy |
$1,616,536 |
City of Hope, Beckman Research Institute |
Dr. Saswati Chatterjee |
Quest – Discovery Stage Research Projects |
Genome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A |
$2,182,193 |
University of California, Irvine |
Dr. Brian J. Cummings |
Quest – Discovery Stage Research Projects |
Identification and characterization of the optimal human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI) 2.0. |
$1,671,213 |
University of California, Los Angeles |
Dr. Vaithilingaraja Arumugaswami PhD |
Quest – Discovery Stage Research Projects |
Immunization strategies to prevent Zika viral congenital eye and brain disease |
$2,128,867 |
Rumi Scientific CA |
Ali H. Brivanlou |
Quest – Discovery Stage Research Projects |
Discovery of therapeutics for Huntington’s Disease |
$1,399,800 |
University of California, Los Angeles |
UCLA Gay M Crooks |
Quest – Discovery Stage Research Projects |
Platform Technology for Pluripotent Stem Cell-Derived T cell Immunotherapy |
$965,636 |
X-Therma Inc. |
Dr. Xiaoxi Wei |
Quest – Discovery Stage Research Projects |
Non-Toxic, Highly-Effective Bioinspired Cryoprotectants for On-Demand Stem Cell Therapies |
$887,883 |
University of California, Los Angeles |
Dr. Caroline Y. Kuo |
Quest – Discovery Stage Research Projects |
Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome |
$1,512,333 |
University of California, Davis |
Dr. Deborah K Lieu |
Quest – Discovery Stage Research Projects |
Microenvironment for hiPSC-derived pacemaking cardiomyocytes |
$2,042,438 |
Stanford University |
Dr. Mark Mercola |
Quest – Discovery Stage Research Projects |
Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI |
$1,809,234 |
University of California, San Diego |
Professor Yuan Chen |
Quest – Discovery Stage Research Projects |
A Novel Approach to Eradicate Cancer Stem Cells |
$279,977 |
City of Hope, Beckman Research Institute |
Professor Yuan Chen |
Quest – Discovery Stage Research Projects |
A Novel Approach to Eradicate Cancer Stem Cells |
$1,539,935 |
University of California, Berkeley |
Kevin E. Healy |
Quest – Discovery Stage Research Projects |
Human Cardiac Chip for Assessment of Proarrhythmic Risk |
$899,581 |
University of California, San Francisco |
Dr. Holger F Willenbring |
Quest – Discovery Stage Research Projects |
Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis |
$1,638,389 |
Scaled Biolabs Inc. |
Dr Justin Cooper-White |
Quest – Discovery Stage Research Projects |
A tool for rapid development of clinical-grade protocols for dopaminergic neuronal differentiation of Parkinson’s Disease patient-derived iPSCs |
$657,528 |
City of Hope, Beckman Research Institute |
Markus Müschen |
Quest – Discovery Stage Research Projects |
Lgr5-mediated self-renewal in B cell selection and leukemia-initiation |
$2,183,223 |
University of California, San Diego |
Professor Alysson R Muotri |
Quest – Discovery Stage Research Projects |
A treatment for Zika virus infection and neuroprotection efficacy |
$1,924,524 |
Stanford University |
Dr. Matthew H Porteus |
Quest – Discovery Stage Research Projects |
Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells |
$1,968,456 |
University of California, San Francisco |
Dr. Julie B Sneddon |
Quest – Discovery Stage Research Projects |
Designing a cellular niche for transplantation of human embryonic stem cell-derived beta cells |
$2,006,076 |
University of California, Los Angeles |
Dr. John P Chute |
Quest – Discovery Stage Research Projects |
Protein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration |
$2,115,735 |
University of California, San Diego |
Dan S Kaufman |
Quest – Discovery Stage Research Projects |
Targeted off-the-shelf immunotherapy to treat refractory cancers |
$1,936,936 |
Parkinson’s Institute |
Dr. Birgitt Schuele |
Quest – Discovery Stage Research Projects |
CRISPR/dCas9 mutant targeting SNCA promoter for downregulation of alpha-synuclein expression as a novel therapeutic approach for Parkinson’s disease |
$1,288,415 |